MK-7243-022

· ALK-Abelló A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-7243-022, covering 2014-03-06 to 2014-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)